S-100β protein as a biomarker in acute hemorrhagic stroke

Omkar Prasad Baidya, Susmita Chaudhuri, Ksh Gomti Devi

Abstract


Acute hemorrhagic stroke, a subtype of acute stroke is one of the leading causes of death and disability throughout the world. At present, the diagnosis of acute hemorrhagic stroke is mainly based on Computer Tomography (CT) or Magnetic Resonance Imaging (MRI) but till now no biomarkers are routinely used in acute hemorrhagic stroke management. This article is a critical and descriptive review on the role of S100β protein as a biomarker in acute hemorrhagic stroke. Plasma S-100β level increases significantly in acute hemorrhagic stroke patients when compared to the normal subjects. Beside, the plasma S-100β can be correlated to the volume of hemorrhage in brain measured by plane CT scan. Plasma S-100β is an useful biomarker in acute hemorrhagic stroke and can be used for estimation of volume of hemorrhage in brain in acute hemorrhagic stroke patients. Thus, S-100β can be useful as an alternative to CT scan/MRI in diagnosis and in taking therapeutic decision in acute hemorrhagic stroke management. 


Keywords


S-100β, Acute hemorrhagic stroke, Biomarker

Full Text:

PDF

References


Smith WS, English JD, Johnson SC. Cerebrovascular Diseases. In: Favei AS, Bravnald E, Kasper DL, Hsusor SL, Longo DL, Joneson J, et al, editors. Harrison’s principles of internal medicine. 17th ed. USA: McGraw Hills; 2008. p.2513-35.

Allen CMC, Lueck CJ. Cerebrovascular Diseases. In: Haslett Ch, Chilvers ER, Boon NA, Colledge NR, editors. Davidson’s principles and practice of Medicine.19th ed. India: Churchill Livingston: 2002. p.1159-68.

Lynch J, Blessing R, White DW, Grocott PH, Newman FM, Laskowitz TD. Novel Diagnostic Test for Acute Stroke. Stroke 2004:35:57-63.

Rothermundt M, Peters M, Prehn HMJ, Arott V. S-100β in brain damage and neurodegeneration. Micros Res Tech 12 Mar 2003;60(6):614-32.

J Sen, A Belli.S-100β in neuropathologic states: the CRP of the brain? J Neurosci Res 2007 May 15;85(7):1373-80.

Heizmann WC. S-100β protein in clinical diagnostic assay specificity. Clin chem 2004;50:249-51.

Nygaard O, Langbakk B, Rommer B. Age and sex related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorders. Clin chem. 1997;43:541-3.

Abdesselam OB, Vally J, Adem C, Foglietti MJ, Beaudeux JL. Reference values for serum S-100β protein depend on the race of individual. Clin Chem 2003;49:836-7.

Huang M, Dong XO, Hu YY, Yu WH, Zhang ZY. High S-100β levels in cerebrospinal fluid and peripheral blood of patients with acute basal ganglial hemorrhage are associated with poor outcome. World J Emerg Med 2010;1(1):22-31.

Liao Q, Liang D, Wang W, Lin N. Association of serum protein S-100β in intracerebral hemorrhage patients with nerve function lesion. Acta Academia Medicina Militaris Tertiac 2005;14:14-5.

Tanaka Y, Marumo T, Omura T, Yoshida S. Early increases in serum S-100β are associated with cerebral hemorrhage in rat model of focal cerebral ischemia. Brain Res 2008 Aug;1227:248-54.

Ali MS, Harmer M, Vaughan R. Serum S-100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaes 2000; 85: 287-98.

Raabe A, Volker S. Protein S-100β as a serum marker of brain damage in severe head injury: preliminary results. Neurosurg Rev 2000;23:136-8.

Delgato P, Sobin JA ,Santamarina E, Molina CA, Quintana M, Rosell A. Plasma S-100β level after acute spontaneous intracerebral hemorrhage. Stroke 2006;37:2837-9.

Tanaka Y, Marumo T, Shibuta H, Omura T, Yoshida S. Serum S-100B, brain edema, and hematoma formation in a rat model of collagenase –induced hemorrhagic stroke. Brain Res Bull 2009 Mar;78(4):158-63.

Weglewski A, Ryglewicz D, Mular A, Jurynczyk J. Changes of protein S-100β serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion. Neurol Neurochir P 2005;39(4):310-7.

James ML, Blessing R, Bute BGP, Bennett E, Laskowitz DT. S-100β and BNP predict functional outcome after intracerebral hemorrhage. Biomark 2009 Sep;14(6):388-94.

Hu YY, Dong Y, Zang Z. Change in plasma S100B level after acute spontaneous basal ganglia hemorrhage. Shock 2010 Feb;33(2):134-40.

Foerch C ,Wunderlich MT, Dvovak F, Humpich M, Kahles T, Goertler M. Elevated serum S-100β levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 2007;38:2491-5.

Montaner J, Mendioroz M, Delgado P, García-Berrocoso T, Giralt D, Merino C, et al. Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway. J Proteomics 2012 Aug 3;75(15):4758-65.

Kavalci C, Genchallac H, Durukan P, Cevik Y. Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke. Bratisl Lek Listy 2011;112(7):398-401.